NAM
EXAS

Nissay Asset Management’s Exact Sciences EXAS Stock Holding History

Nissay Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,432
Closed -$971K – 712
2025
Q1 		$971K Buy
22,432
+187
+0.8% +$9.47K 0.01% 630
2024
Q4 		$1.28M Buy
22,245
+179
+0.8% +$11.1K 0.01% 604
2024
Q3 		$1.5M Buy
22,066
+952
+5% +$53.7K 0.01% 588
2024
Q2 		$892K Buy
21,114
+494
+2% +$27.2K 0.01% 654
2024
Q1 		$1.42M Buy
20,620
+343
+2% +$21.7K 0.01% 578
2023
Q4 		$1.5M Buy
20,277
+749
+4% +$49.1K 0.01% 538
2023
Q3 		$1.33M Buy
19,528
+872
+5% +$74K 0.01% 543
2023
Q2 		$1.75M Sell
18,656
-376
-2% -$29.3K 0.02% 480
2023
Q1 		$1.29M Sell
19,032
-834
-4% -$53.6K 0.01% 540
2022
Q4 		$984K Sell
19,866
-29
-0.1% -$1.19K 0.01% 598
2022
Q3 		$646K Buy
19,895
+949
+5% +$39.1K 0.01% 650
2022
Q2 		$746K Buy
18,946
+483
+3% +$25.8K 0.01% 632
2022
Q1 		$1.29M Buy
18,463
+471
+3% +$34.4K 0.01% 568
2021
Q4 		$1.4M Buy
17,992
+779
+5% +$68.8K 0.01% 574
2021
Q3 		$1.64M Buy
17,213
+916
+6% +$96.7K 0.01% 507
2021
Q2 		$2.03M Buy
16,297
+1,444
+10% +$172K 0.02% 445
2021
Q1 		$1.96M Sell
14,853
-362
-2% -$49.6K 0.02% 433
2020
Q4 		$2.02M Buy
15,215
+664
+5% +$80.3K 0.03% 394
2020
Q3 		$1.48M Buy
14,551
+548
+4% +$47.3K 0.03% 429
2020
Q2 		$1.22M Buy
14,003
+1,526
+12% +$122K 0.02% 471
2020
Q1 		$724K Buy
12,477
+510
+4% +$41.4K 0.02% 505
2019
Q4 		$1.11M Buy
11,967
+1,641
+16% +$144K 0.02% 496
2019
Q3 		$933K Buy
10,326
+769
+8% +$87.6K 0.02% 514
2019
Q2 		$1.13M Buy
+9,557
New +$963K 0.03% 461

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Nissay Asset Management's EXAS Position: Q2 2025 in Review

Nissay Asset Management sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 22,432 shares — an estimated $971K sold.

Nissay Asset Management first reported a position in EXAS in Q2 2019 and held it in 24 quarters. The position peaked at $2.03M in Q2 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Nissay Asset Management reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Nissay Asset Management sold 22,432 Exact Sciences shares in Q2 2025, an estimated $971K.
  • Nissay Asset Management first reported a position in Exact Sciences in Q2 2019 and held it in 24 quarters.
  • Nissay Asset Management's Exact Sciences position peaked at $2.03M in Q2 2021.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Nissay Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.